article21 February 2023 | By Arthur Wakeley, Catherine Eckford (European Pharmaceutical Review), James Short
Following on from the first GMP registration of a cannabis API for a UK pharmaceutical facility, EPR spoke with Celadon Pharmaceuticals about how it navigated the complex regulatory landscape.